STVN,NAMI Stock Price and Quote

Jun 25, 10:02 AMDeora pen injector launch and analyst upgrades drive STVN's 6.49% gain

Peers: ICUI TFX AVTR BDX BAX RMD MASI EW BSX MDT

| Held by: IBB KOMP NBSM BCSM AIMS SMLV BCGD TMED

Index	-	P/E	30.61	EPS (ttm)	0.60	Insider Own	81.79%	Shs Outstand	49.71M	Perf Week	7.80%
Market Cap	5.02B	Forward P/E	22.30	EPS next Y	0.82	Insider Trans	-0.00%	Shs Float	49.71M	Perf Month	2.34%
Enterprise Value	5.41B	PEG	1.30	EPS next Q	0.15	Inst Own	17.37%	Short Float	1.83%	Perf Quarter	29.69%
Income	164.01M	P/S	3.60	EPS this Y	12.90%	Inst Trans	-2.24%	Short Ratio	1.78	Perf Half Y	-10.42%
Sales	1.40B	P/B	2.85	EPS next Y	18.97%	ROA	5.98%	Short Interest	0.91M	Perf YTD	-8.60%
Book/sh	6.46	P/C	39.02	EPS next 5Y	17.21%	ROE	9.96%	52W High	28.00 -34.32%	Perf Year	-27.17%
Cash/sh	0.47	P/FCF	867.11	EPS past 3/5Y	0.64% 11.33%	ROIC	7.68%	52W Low	12.89 42.67%	Perf 3Y	-42.67%
Dividend Est.	0.05 (0.30%)	EV/EBITDA	16.25	Sales past 3/5Y	9.00% 12.15%	Gross Margin	28.10%	Volatility	5.02% 5.01%	Perf 5Y	-
Dividend TTM	0.06 (0.34%)	EV/Sales	3.88	EPS Y/Y TTM	21.77%	Oper. Margin	16.26%	ATR (14)	0.89	Perf 10Y	-
Dividend Ex-Date	Jun 11, 2026	Quick Ratio	1.11	Sales Y/Y TTM	15.54%	Profit Margin	11.76%	RSI (14)	59.51	Recom	1.33
Dividend Gr. 3/5Y	0.00% -	Current Ratio	1.63	EPS Q/Q	17.40%	SMA20	3.49%	Beta	0.77	Target Price	23.93
Payout	10.76%	Debt/Eq	0.29	Sales Q/Q	18.52%	SMA50	5.74%	Rel Volume	0.48	Prev Close	17.24
Employees	-	LT Debt/Eq	0.21	Earnings	May 07 BMO	SMA200	-6.05%	Avg Volume	510.06K	Price	18.39
IPO	Jul 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.16% 2.37%	Trades		Volume	243,187	Change	6.67%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-26	Initiated	TD Cowen	Buy	$25
Jun-02-26	Resumed	Wolfe Research	Outperform	$21
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight	$24
Dec-13-24	Initiated	Wolfe Research	Outperform	$28
Dec-03-24	Resumed	Morgan Stanley	Equal-Weight	$23
Apr-22-24	Initiated	Exane BNP Paribas	Outperform
Nov-01-23	Downgrade	Jefferies	Buy → Hold	$39 → $29
Sep-26-23	Initiated	Stephens	Overweight	$33
Sep-19-23	Initiated	CJS Securities	Market Outperform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$34
Aug-10-21	Initiated	Wells Fargo	Overweight	$24
Aug-10-21	Initiated	Morgan Stanley	Overweight	$26
Aug-10-21	Initiated	KeyBanc Capital Markets	Overweight	$27
Aug-10-21	Initiated	Jefferies	Buy	$25
Aug-10-21	Initiated	Citigroup	Buy	$27
Aug-10-21	Initiated	BofA Securities	Buy	$26

Show Previous Ratings

Jun-08-26 06:30AM	Stevanato Group Introduces Deora, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management (Business Wire)
Jun-03-26 05:45PM	Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders' Meeting (Business Wire)
May-08-26 08:30AM	Stevanato Group S.p.A. Q1 2026 Earnings Call Summary (Moby)
May-07-26 06:41AM	Stevanato: Q1 Earnings Snapshot (Associated Press) -5.11%
06:30AM	Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026 (Business Wire)
05:45PM	Loading…
May-04-26 05:45PM	Stevanato Group to Participate in Three Upcoming Investor Conferences (Business Wire)
Apr-23-26 04:05PM	Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026 (Business Wire)
Mar-12-26 04:45PM	Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum (Business Wire)
Mar-04-26 04:01PM	Stevanato Group SpA (STVN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +18.81% -9.09%
01:47PM	Stevanato Group Q4 Earnings Call Highlights (MarketBeat)
12:35PM	Stevanato Group S.p.A. Q4 2025 Earnings Call Summary (Moby)
07:45AM	Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
06:48AM	Stevanato: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins (Business Wire)
Feb-26-26 09:55AM	Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:35AM	Loading…
Feb-19-26 07:35AM	Here's What Hurt Stevanato Group SpA (STVN) in Q4 (Insider Monkey)
06:30AM	Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026 (Business Wire)
Jan-26-26 11:40AM	STVN or MDGL: Which Is the Better Value Stock Right Now? (Zacks)
Jan-23-26 04:34PM	Stocks Finish Mostly Higher Despite a Plunge in Intel (Barchart) -9.86%
Jan-20-26 09:05AM	Stevanato (STVN) Declined Due to Anticipation of Soft Quarter Ahead (Insider Monkey)
Jan-16-26 05:05AM	Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs (PR Newswire) -5.95%
Dec-24-25 08:34AM	Are Options Traders Betting on a Big Move in Stevanato Group Stock? (Zacks)
Dec-19-25 11:40AM	SDZNY vs. STVN: Which Stock Is the Better Value Option? (Zacks)
Dec-03-25 11:40AM	SDZNY vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks) +5.70%
Nov-06-25 07:45AM	Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:38AM	Stevanato: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Stevanato Group Reports Revenue of 303.2 Million for the Third Quarter of 2025 (Business Wire)
Oct-31-25 12:09PM	SDZNY vs. STVN: Which Stock Is the Better Value Option? (Zacks)
07:30AM	Stevanato Group to Participate in Upcoming Investor Conferences (Business Wire)
Oct-22-25 06:30AM	Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025 (Business Wire)
06:30AM	Loading…
Oct-21-25 06:30AM	Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings (Business Wire)
Oct-10-25 11:40AM	GRFS vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks)
Oct-07-25 06:04AM	NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock? (Zacks)
Sep-15-25 11:40AM	USNA vs. STVN: Which Stock Is the Better Value Option? (Zacks)
Sep-12-25 08:16AM	Stevanato Group SpA (STVN) Share Gained 20% as Results Exceeded Expectations (Insider Monkey)
Sep-11-25 12:00PM	Stevanato (STVN) Upgraded to Buy: Here's What You Should Know (Zacks)
Sep-02-25 05:59PM	Stevanato Group to Participate in Upcoming Investor Conferences (Business Wire)
Aug-28-25 11:40AM	USNA or STVN: Which Is the Better Value Stock Right Now? (Zacks)
Aug-25-25 08:30AM	Here's Why Artisan Small Cap Fund Increased its Holdings in Stevanato Group S.p.A. (STVN) (Insider Monkey)
Aug-12-25 11:40AM	USNA vs. STVN: Which Stock Is the Better Value Option? (Zacks)
Aug-05-25 07:40AM	Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates (Zacks) -9.73%
06:38AM	Stevanato: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	Stevanato Group Reports Revenue of 280.0 Million for the Second Quarter of 2025 (Business Wire)
Jul-29-25 10:00AM	Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-25-25 11:40AM	MKKGY or STVN: Which Is the Better Value Stock Right Now? (Zacks) -5.15%
10:06AM	Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock? (Zacks)
Jul-23-25 01:18PM	Will Escalating Medical Costs Dampen Centene's Q2 Earnings? (Zacks)
06:30AM	Stevanato Group Secures 200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S. (Business Wire)
Jul-22-25 04:30PM	Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025 (Business Wire)
Jul-09-25 11:40AM	CPRX or STVN: Which Is the Better Value Stock Right Now? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FMS or RXST: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	GBOOY vs. BAM: Which Stock Should Value Investors Buy Now? (Zacks)
11:40AM	FLEX vs. GRMN: Which Stock Is the Better Value Option? (Zacks)
11:40AM	GLDD vs. DY: Which Stock Is the Better Value Option? (Zacks)
11:40AM	DNBBY or CMWAY: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	CCU or SAM: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	TTEC or MLNK: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	STRT or RACE: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	STNE vs. FFIV: Which Stock Is the Better Value Option? (Zacks)
11:40AM	GO or KMB: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	CRRFY or WMT: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	ASAIY vs. K: Which Stock Is the Better Value Option? (Zacks)
11:40AM	USNA vs. STVN: Which Stock Is the Better Value Option? (Zacks)
Jun-02-25 11:40AM	GRFS vs. STVN: Which Stock Is the Better Value Option? (Zacks)
May-30-25 01:07AM	Stevanato Group S.p.A. (STVN): A Bull Case Theory (Insider Monkey)
May-09-25 04:03PM	Stevanato Group to Participate in Upcoming Investor Conferences (Business Wire) +6.76%
03:20AM	Stevanato Group SpA (STVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-08-25 07:50AM	Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates (Zacks)
06:46AM	Stevanato: Q1 Earnings Snapshot (Associated Press Finance)
06:37AM	Stevanato Group Reports Revenue of 256.6 Million for the First Quarter of 2025 (Business Wire)
May-07-25 09:41AM	Stevanato Group SpA (STVN) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
May-06-25 11:40AM	SDZNY vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks)
08:55AM	Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-24-25 05:15PM	Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
Mar-11-25 04:30PM	Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum (Business Wire) -6.46%
Mar-07-25 02:09AM	Stevanato Group SpA (STVN) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
01:52AM	Q4 2024 Stevanato Group SpA Earnings Call (Thomson Reuters StreetEvents)
Mar-06-25 07:45AM	Stevanato Group (STVN) Meets Q4 Earnings Estimates (Zacks) +8.60%
06:48AM	Stevanato: Q4 Earnings Snapshot (Associated Press Finance)
06:31AM	Stevanato Group Reports Record Revenue of 1,104 Million for Fiscal Year 2024 (Business Wire)
Mar-05-25 07:05AM	Earnings To Watch: Stevanato Group SpA (STVN) Reports Q4 2024 Result (GuruFocus.com)
Feb-24-25 04:02PM	Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025 (Business Wire)
Feb-23-25 01:35PM	Stevanato Group S.p.A. (STVN): the Most Oversold Pharma Stock to Buy According to Analysts (Insider Monkey)
Feb-13-25 12:16AM	Is Stevanato Group S.p.A. (STVN) the Best Italian Stock to Buy in 2025? (Insider Monkey) -5.08%
Jan-07-25 04:30PM	Stevanato Group to Present at Upcoming Investor Conference (Business Wire)
Dec-14-24 06:45AM	Wolfe starts Stevanato with Outperform on return to growth (TipRanks)
Dec-04-24 07:55AM	Stevanato Group assumed with an Equal Weight at Morgan Stanley (TipRanks)
Nov-11-24 06:32AM	Stevanato Group to Present at Upcoming Investor Conferences (Business Wire)
Nov-06-24 02:13AM	Stevanato Group SpA (STVN) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Nov-05-24 07:45AM	Stevanato Group (STVN) Q3 Earnings Match Estimates (Zacks) +16.10%
06:43AM	Stevanato: Q3 Earnings Snapshot (Associated Press Finance)
06:31AM	Stevanato Group Reports Financial Results for the Third Quarter of 2024 (Business Wire)
Nov-04-24 07:03AM	Stevanato Group SpA (STVN) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Oct-22-24 04:30PM	Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024 (Business Wire)
10:01AM	Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-08-24 07:25AM	Nipro debuts D2F glass vials with Stevanatos EZ-fill tech (Packaging Gateway)
Oct-01-24 06:30AM	Stevanato Group Will Introduce Its Large-Volume Vertiva 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan (Business Wire)
Sep-30-24 11:31AM	Is Stevanato Group S.p.A. (STVN) the Top Italian Stock for Biopharma Investors? (Insider Monkey) -6.24%
Sep-27-24 10:48AM	Heres Why ClearBridge SMID Cap Growth Strategy Exited Stevanato (STVN) (Insider Monkey)

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

CEO & Executive ChairmanMr. Franco Stevanato

Chief Financial OfficerMr. Marco Dal Lago

Chief Communications & Investor Relations OfficerMs. Lisa Miles

Chief Human Resources OfficerMs. Carla Costa

Chief Business OfficerMr. Mauro Stocchi

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Balachandran Madhavan	Director	Jun 15 '26	Sale	17.09	1,493	25,515	69,458	Jun 26 06:18 AM
Dal Lago Marco	Chief Financial Officer	Jun 12 '26	Option Exercise	0.00	7,997	0	85,353	Jun 26 06:16 AM
MOREL DONALD E JR	Director	Jun 15 '26	Sale	17.09	1,493	25,515	37,424	Jun 26 06:12 AM
Stocchi Mauro	See Remarks	Jun 09 '26	Option Exercise	0.00	6,586	0	413,629	Jun 26 06:07 AM
Flynn Karen	Director	Jun 15 '26	Sale	17.09	1,493	25,515	5,757	Jun 26 06:05 AM
FEDERICI WILLIAM J	Director	Jun 15 '26	Sale	17.09	1,493	25,515	26,991	Jun 26 06:04 AM

NAMI Jinxin Technology Holding Co ADR daily Stock Chart

Peers: GIFT SJ SOGP ZDGE AREN BODI BZFD TEAD DIBS WSHP

Index	-	P/E	-	EPS (ttm)	-4.74	Insider Own	-	Shs Outstand	3.16M	Perf Week	-30.00%
Market Cap	13.73M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-55.14%
Enterprise Value	8.98M	PEG	-	EPS next Q	-	Inst Own	0.00%	Short Float	-	Perf Quarter	-80.92%
Income	-13.19M	P/S	0.24	EPS this Y	-	Inst Trans	-64.29%	Short Ratio	0.38	Perf Half Y	-73.73%
Sales	57.45M	P/B	1.14	EPS next Y	-	ROA	-43.36%	Short Interest	0.01M	Perf YTD	-77.29%
Book/sh	3.79	P/C	1.21	EPS next 5Y	-	ROE	-87.69%	52W High	51.25 -91.53%	Perf Year	-83.40%
Cash/sh	3.59	P/FCF	-	EPS past 3/5Y	- 0.43%	ROIC	-107.54%	52W Low	3.38 28.59%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	17.84% 10.55%	Gross Margin	10.88%	Volatility	28.74% 19.65%	Perf 5Y	-
Dividend TTM	-	EV/Sales	0.16	EPS Y/Y TTM	-532.88%	Oper. Margin	-25.37%	ATR (14)	1.26	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.47	Sales Y/Y TTM	1.73%	Profit Margin	-22.96%	RSI (14)	28.82	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.53	EPS Q/Q	-945.65%	SMA20	-32.92%	Beta	-3.22	Target Price	-
Payout	-	Debt/Eq	0.24	Sales Q/Q	-1.14%	SMA50	-51.33%	Rel Volume	3.17	Prev Close	4.97
Employees	107	LT Debt/Eq	0.02	Earnings	-	SMA200	-72.95%	Avg Volume	30.89K	Price	4.34
IPO	Dec 06, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	93,705	Change	-12.76%

Jun-23-26 06:00AM	Jinxin Technology Holding Company Announces Plan to Implement ADS Ratio Change (PR Newswire)
Mar-27-26 07:05AM	NamiBox Expands into AI Educational Companion Devices with NAMI COMPANION Series, Introducing a New Growth Vector in Smart Learning Hardware (PR Newswire) -9.98%
Feb-02-26 08:00AM	Jinxin Technology Holding Company Announces Receipt of Nasdaq Notice (PR Newswire) +12.26%
Jan-09-26 09:00AM	NAMI INSIGHT One Debuts at CES 2026, Positioning Namibox at the Forefront of the AI Learning Wearables Market (PR Newswire)
Dec-31-25 09:00AM	Namibox Launches NAMI INSIGHT One, Introducing a New Category of AI-native Wearable Learning Devices (PR Newswire) -6.79%
09:00AM	Loading…
Dec-15-25 09:00AM	Namibox Unveils World's First AI-Powered Learning Glasses, Set for December 31, 2025 Release - AI Powered Education Hardware Opens Up New Growth Curve (PR Newswire) -21.53%
Oct-29-25 09:15AM	At Just 35g with Full-Color Binoculars- Namibox's AI Learning Glasses Are Set to Launch This December (PR Newswire)
Oct-22-25 09:30AM	Jinxin Announces US$2 Million Share Repurchase Program (PR Newswire) +5.52%
Sep-10-25 09:00AM	Namibox and Partners Forge Cross-Border Collaboration as "AI Zhixuetong App" Launches a New Era of Smart Education in Hong Kong and Macau (PR Newswire) +12.75%
Aug-27-25 09:30AM	Namibox Set to Launch World's First AI-Powered Learning Glasses (PR Newswire) +33.01%
May-29-25 09:30AM	Namibox, Tencent Cloud, and Shenzhen Press Group Publishing House Forge Tripartite Strategic Partnership to Build a Full-chain AI Education Ecosystem (PR Newswire) -53.66%
Apr-22-25 12:19AM	Jinxin Technology: Turning Pages In EdTech, But The Story Isn't Over Yet (Seeking Alpha)
Mar-31-25 09:30AM	NamiBox and Tencent Cloud Announce Strategic Partnership with Sichuan Education Press to Launch AI-Powered Writing Solution (PR Newswire)
Mar-26-25 09:30AM	Jinxin Technology Issues 2025 Financial Guidance: Projects 70 Million USD in Revenue, Driven by AI-Powered Content Expansion and Strategic Partnerships (PR Newswire)
Mar-18-25 09:45AM	Jinxin Technology Holding Company (Nasdaq: NAMI) Expands Partnership with China Mobile to Drive 5G New Call Innovation (PR Newswire)
06:00AM	Loading…
Mar-07-25 06:00AM	Namibox Integrates DeepSeek AI Model, Pioneering Innovation in K9 Digital Education (PR Newswire) -7.61%
Feb-21-25 06:00AM	Namibox and Hisense Form Strategic Collaboration to Launch the "Parent-Child Learning Big Screen," Creating a New Ecosystem of "Educational Hardware + Emotional Economy" (PR Newswire)
Feb-13-25 06:00AM	Namibox, Tencent, and Sichuan Education Press Forge Strategic Partnership to Develop Innovative AI-Powered Learning Solutions (PR Newswire) +16.46%
Dec-10-24 12:52PM	WestPark Capital Announces Closing of $5 Million IPO for Jinxin Technology Holding Company (Nasdaq: NAMI) (Business Wire)
Dec-09-24 11:00PM	Jinxin Technology Holding Company Announces Closing of US$5 Million Initial Public Offering (PR Newswire)
03:02PM	Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Jinxin Technology Holding Company (Business Wire)
Dec-05-24 10:50PM	Jinxin Technology Holding Company Announces Pricing of US$5 Million Initial Public Offering (PR Newswire)

Jinxin Technology Holding Co. engages in the provision of digital content services. It focuses on providing digital and integrated educational content. The company was founded by Jin Xu in 2014 and is headquartered in Shanghai, China.

FounderMr. Jin Xu

Co-FounderMr. Jun Jiang

Co-Founder & Chief Technology OfficerMr. Feifei Huang

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jiang Jun Jason	CFO and COO	Jun 24 '26	Sale	0.20	4	1	2,788,032	Jun 26 06:01 AM
Jiang Jun Jason	CFO and COO	Jun 22 '26	Sale	0.24	2	0	2,798,032	Jun 24 06:22 AM
Jiang Jun Jason	CFO and COO	Jun 17 '26	Sale	0.23	11,000	2,511	2,799,034	Jun 22 06:19 AM
Jiang Jun Jason	CFO and COO	Jun 18 '26	Sale	0.24	1,000	236	2,798,034	Jun 22 06:19 AM
Jiang Jun Jason	CFO and COO	Jun 11 '26	Sale	0.28	5,000	1,380	2,810,034	Jun 15 06:01 AM
Jiang Jun Jason	CFO and COO	Jun 10 '26	Sale	0.32	40,000	12,950	2,815,034	Jun 12 06:04 AM
Jiang Jun Jason	CFO and COO	Jun 09 '26	Sale	0.29	10,000	2,900	2,855,034	Jun 11 06:08 AM
Jiang Jun Jason	CFO & COO	Jun 08 '26	Sale	0.34	58,000	19,893	2,865,034	Jun 10 06:27 AM
Jiang Jun Jason	CFO and COO	Jun 05 '26	Sale	0.27	932	247	2,923,034	Jun 09 06:12 AM
Jiang Jun Jason	CFO and COO	Jun 04 '26	Sale	0.27	10,000	2,695	2,923,966	Jun 08 06:06 AM
Jiang Jun Jason	CFO and COO	Jun 03 '26	Sale	0.29	41,364	11,905	2,933,966	Jun 05 06:13 AM
Jiang Jun Jason	Chief Financial Officer & COO	Jun 02 '26	Sale	0.28	500	139	2,975,330	Jun 04 06:23 AM
Jiang Jun Jason	CFO and COO	Jun 01 '26	Sale	0.29	2,000	584	2,975,830	Jun 03 06:10 AM
Jiang Jun Jason	CFO and COO	May 29 '26	Sale	0.30	2,000	592	2,977,830	Jun 02 06:23 AM
Jiang Jun Jason	Chief Financial Officer & COO	May 28 '26	Sale	0.30	8,500	2,562	2,979,830	Jun 01 06:15 AM
Jiang Jun Jason	CFO and COO	May 27 '26	Sale	0.34	10,100	3,481	2,988,330	May 29 06:15 AM
Jiang Jun Jason	CFO and COO	May 26 '26	Sale	0.33	27,000	9,011	2,998,430	May 28 06:10 AM
Jiang Jun Jason	CFO and COO	May 21 '26	Sale	0.35	7,000	2,427	3,026,370	May 26 08:00 AM
Jiang Jun Jason	CFO and COO	May 22 '26	Sale	0.30	940	287	3,025,430	May 26 06:34 AM
Jiang Jun Jason	CFO and COO	May 20 '26	Sale	0.33	61,760	20,676	3,033,370	May 22 06:07 AM
Jiang Jun Jason	CFO & COO	May 19 '26	Sale	0.36	2,000	722	3,095,130	May 21 06:03 AM
Jiang Jun Jason	CFO and COO	May 18 '26	Sale	0.37	1,900	699	3,097,130	May 20 06:02 AM
Jiang Jun Jason	CFO and COO	May 15 '26	Sale	0.36	1,000	360	3,099,030	May 19 06:08 AM
Jiang Jun Jason	CFO AND COO	May 14 '26	Sale	0.36	1,900	687	3,100,030	May 18 06:04 AM
Jiang Jun Jason	CFO and COO	May 13 '26	Sale	0.35	1,500	532	3,101,930	May 15 06:59 AM
Jiang Jun Jason	CFO and COO	May 12 '26	Sale	0.31	36	11	3,103,430	May 14 07:12 AM
Jiang Jun Jason	CFO and COO	May 11 '26	Sale	0.36	1,000	364	3,103,466	May 13 06:32 AM
Jiang Jun Jason	CFO and COO	May 08 '26	Sale	0.38	1,790	674	3,104,466	May 12 06:05 AM
Jiang Jun Jason	CFO and COO	May 07 '26	Sale	0.38	1,610	608	3,106,256	May 11 06:04 AM
Jiang Jun Jason	CFO and COO	May 06 '26	Sale	0.37	251	94	3,107,866	May 11 06:04 AM
Jiang Jun Jason	CFO and COO	May 05 '26	Sale	0.39	1,000	394	3,108,117	May 07 06:01 AM
Jiang Jun Jason	CFO and COO	May 01 '26	Sale	0.39	500	197	3,109,117	May 05 06:03 AM
Jiang Jun Jason	CFO and COO	Apr 30 '26	Sale	0.39	1,494	583	3,109,617	May 04 06:02 AM
Jiang Jun Jason	Director and Chief Operating O	Apr 30 '26	Proposed Sale	0.45	790,000	355,737		Apr 29 06:46 AM

STVN

Stevanato Group Spa

NAMI

Jinxin Technology Holding Co ADR

Upgrade your Finviz experience